Statistics for Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide

Total visits

views
Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide 0

Total visits per month

views
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0

File Visits

views
124.pdf 5